Defunct Company
Total Trials
4
As Lead Sponsor
As Collaborator
0
Total Enrollment
340
NCT05687435
Changyanning Tablet for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Phase: Phase 2/3
Role: Lead Sponsor
Start: Jan 30, 2023
Completion: Apr 30, 2024
NCT05947396
Randomized Control Trial of Small-Molecule Natural Flavonoids Intervention for Neurodegenerative Diseases
Phase: N/A
Start: Aug 15, 2023
Completion: Dec 31, 2024
NCT05947409
Single Arm Clinical Trial of Small Molecule Natural Flavonoid Compounds for Intervention in Neurodegenerative Diseases
NCT06371196
Clinical Study on the Treatment of Elevated Total Bilirubin in Primary Biliary Cholangitis With Baobao Dan Capsule
Phase: Phase 4
Start: Apr 25, 2024
Completion: Dec 31, 2025